A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host disease. (Q47608492)
scientific article
Language:
(P31) (Q13442814)
(P304) 4066-4071
(P407) (Q1860)
(P433) 11
(P478) 92
(P577) Tuesday, December 1, 1998
(P1433) (Q885070)
(P1476) "A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host disease" (language: en)
(P2093) Przepiorka D
Phillips GL
Ratanatharathorn V
Cottler-Fox M
Sehn LH
Antin JH
LeBherz D
Awwad M
Hope J
McClain JB
other details
description scientific article

External Links